The FDA is launching a campaign against unsafe use of certain narcotics, pointing to a growing misuse of painkillers over the past decade.

QRxPharma Limited, a clinical-stage specialty pharmaceutical company focused on the development and commercialization of therapies for pain and central nervous system disorders, announced today that the U.S.…
Read full story from Med Ad News